Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA3 | P0DMS8 | 6/20 | 0.64 |
| ▸ | PRKAG1 | P54619 | 1/20 | 0.57 |
| ▸ | PRKAA1 | Q13131 | 1/20 | 0.57 |
| ▸ | PRKAB1 | Q9Y478 | 1/20 | 0.57 |
| ▸ | SLC29A1 | Q99808 | 2/20 | 0.55 |
| ▸ | DNPH1 | O43598 | 1/20 | 0.54 |
| ▸ | TP53 | P04637 | 1/20 | 0.54 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20626433 | 1.00 | ADORA3 (0.64) | ADORA3PRKAG1PRKAA1PRKAB1SLC29A1 | |
| SCHEMBL14714024 | 1.00 | ADORA3 (0.64) | ADORA3PRKAG1PRKAA1PRKAB1SLC29A1 | |
| SCHEMBL14713295 | 1.00 | ADORA3 (0.64) | ADORA3PRKAG1PRKAA1PRKAB1SLC29A1 | |
| SCHEMBL14714087 | 0.88 | ADORA3 (0.60) | ADORA3PRKAG1PRKAA1PRKAB1SLC29A1 | |
| SCHEMBL20626363 | 0.87 | PRKAG1 (0.75) | ADORA3PRKAG1PRKAA1PRKAB1SLC29A1 | |
| SCHEMBL27898344 | 0.87 | PRKAG1 (0.75) | ADORA3PRKAG1PRKAA1PRKAB1SLC29A1 | |
| SCHEMBL14714098 | 0.87 | PRKAG1 (0.75) | ADORA3PRKAG1PRKAA1PRKAB1SLC29A1 | |
| SCHEMBL20626299 | 0.87 | PRKAG1 (0.75) | ADORA3PRKAG1PRKAA1PRKAB1SLC29A1 | |
| SCHEMBL14713285 | 0.87 | PRKAG1 (0.75) | ADORA3PRKAG1PRKAA1PRKAB1SLC29A1 | |
| SCHEMBL1798219 | 0.86 | PRKAG1 (0.59) | ADORA3PRKAG1PRKAA1PRKAB1SLC29A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10174033-B2 | N6-substituted adenosine derivatives and N6-substituted adenine derivatives and uses thereof | INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF MEDICAL SCIENCES (CN) | 2019-01-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10174033-B2 | N6-substituted adenosine derivatives and N6-substituted adenine derivatives and uses thereof | ADORA2A, ADORA3, ADORA1 | ADORA3 2/4885PRKAG1 115/4885PRKAA1 341/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.